Skip to main content
. 2009 Nov 4;31(1):77–84. doi: 10.1093/eurheartj/ehp483

Table 1.

Baseline characteristics of population by heart failure status

Total (n = 5613) No heart failure (n = 4087) Incident heart failure (n = 1526) P-value
Age (years) (missing data n = 0) 72.74 ± 5.57 72.29 ± 5.45 73.95 ± 5.71 <0.001
BMI (kg/m2) (missing data n = 19) 26.65 ± 4.67 26.38 ± 4.5 27.38 ± 5.02 <0.001
Age at meno (women) (missing data n = 247) 47.04 ± 6.72 47.24 ± 6.54 46.42 ± 7.22 0.01
Male (missing data n = 0) 2362 (42) 1636 (40) 726 (48) <0.01
African American (missing data n = 0) 864 (15) 645 (16) 219 (14) 0.2
Education (≥12 years) (missing data n = 16) 3975 (71) 2938 (72) 1037 (68) <0.001
Income(≥25 000 USD/year) (missing data n = 364) 2047 (39) 1558 (41) 489 (34) <0.001
Live birth (women) (missing data n = 848) 2339 (97) 1761 (97) 578 (98) 0.51
Calcium supplement intake (missing data n = 56) 1093 (20) 802 (20) 291 (19) 0.67

Smoking status (missing data n = 6)
 Never 2602 (46) 1908 (47) 694 (45) 0.55
 Former 2331 (42) 1679 (41) 652 (43)
 Current 674 (12) 495 (12) 179 (12)

Glucose status (missing data n = 58)
 Normal 3935 (71) 2955 (73) 980 (65) <0.001
 IFG 752 (13) 552 (14) 200 (13)
 Diabetes 868 (16) 528 (13) 340 (22)

Frailty status (missing data n = 556)
 Not frail 2402 (47) 1826 (49) 576 (43) <0.001
 Intermediate 2342 (46) 1688 (46) 654 (48)
 Frail 313 (6) 190 (5) 123 (9)

Health status, self-reported (missing data n = 13)
 Excellent 783 (14) 640 (16) 143 (9) <0.001
 Very good 1399 (25) 1084 (27) 315 (21)
 Good 2100 (37) 1491 (36) 609 (40)
 Fair 1124 (20) 743 (18) 381 (25)
 Poor 194 (4) 122 (3) 72 (5)

Oestrogen use (women) (missing data n = 0)
 Never 2003 (62) 1466 (60) 537 (67) <0.001
 Past 874 (27) 685 (28) 189 (24)
 Current 374 (12) 300 (12) 74 (9)

Alcohol use (drinks/week) (missing data n = 51)
 None 2248 (40) 1585 (39) 663 (44) <0.001
 Previous 484 (9) 316 (8) 168 (11)
 <1 1073 (19) 795 (20) 278 (18)
 1 to <7 973 (17) 737 (18) 236 (16)
 7 and more 784 (14) 612 (15) 172 (11)

Kcal/day of physical activity (missing data n = 18) 1738 ± 2045 1793 ± 2084 1591 ± 1930 <0.001
Digital symbol substitution (DSS) (in s) (missing data n = 264) 37 ± 13.4 37.4 ± 13.7 34.8 ± 12.5 <0.001
Cystatin C (mg/L) (missing data n = 676) 1.0 ± 0.3 1.02 ± 0.28 1.12 ± 0.38 <0.001
Gait speed (m/s) (missing data n = 79) 1.1 ± 0.3 1.13 ± 0.28 1.08 ± 0.28 <0.001
Pneumonia (missing data n = 63) 1510 (27) 1073 (26) 437 (29) 0.08
Use of thyroid medications (missing data n = 7) 488 (9) 362 (9) 126 (8) 0.51
Cancer (missing data n = 9) 808 (14) 590 (14) 218 (14) 0.92
Chronic obstructive pulmonary disease (missing data n = 199) 698 (13) 483 (12) 215 (15) 0.02
Vision problems (missing data n = 230) 362 (7) 239 (6) 123 (9) <0.001
Current oral corticosteroid (missing data n = 7) 116 (2) 69 (2) 47 (3) <0.001
Use of cardiac medications (missing data n = 0) 2101 (37) 1398 (34) 703 (46) <0.01

Means ± standard deviations or counts (by percentages).